ILM peeling in nontractional diabetic macular edema: review and metanalysis
- 240 Downloads
To evaluate the effect of internal limiting membrane (ILM) peeling during vitrectomy for nontractional diabetic macular edema.
PUBMED, MEDLINE and CENTRAL were reviewed using the following terms (or combination of terms): diabetic macular edema, nontractional diabetic macular edema, internal limiting membrane peeling, vitrectomy, Müller cells. Randomized and nonrandomized studies were included. The eligible studies compared anatomical and functional outcomes of vitrectomy with or without ILM peeling for tractional and nontractional diabetic macular edema. Postoperative best-corrected visual acuity and central macular thickness were considered, respectively, the primary and secondary outcomes. Meta-analysis on mean differences between vitrectomy with and without ILM peeling was performed using inverse variance method in random effects.
Four studies with 672 patients were eligible for analysis. No significant difference was found between postoperative best-corrected visual acuity or best-corrected visual acuity change of ILM peeling group compared with nonpeeling group. There was no significant difference in postoperative central macular thickness and central macular thickness reduction between the two groups.
The visual acuity outcomes in patients affected by nontractional diabetic macular edema using pars plana vitrectomy with ILM peeling versus no ILM peeling were not significantly different. A larger prospective and randomized study would be necessary.
KeywordsInternal limiting membrane peeling Diabetic macular edema Vitrectomy Müller cells Diabetic retinopathy Meta-analysis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Stehphen J. Ryan. Non proliferative diabetic retinopathy, Chap 67. In: Retina, Vol II, 4th edn. pp 1275–1276Google Scholar
- 10.Bressler SB, Liu D, Glassman AR, Blodi BA, Castellarin AA, Jampol LM, Kaufman PL, Melia M, Singh H, Wells JA, Diabetic Retinopathy Clinical Research Network (2017) Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab. JAMA Ophthalmol 135(6):558–568CrossRefGoogle Scholar
- 11.Khan Z, Kuriakose RK, Khan M, Chin EK, Almeida DR (2017) Efficacy of the intravitreal sustained-release dexamethasone implant for diabetic macular edema refractory to anti-vascular endothelial growth factor therapy: meta-analysis and clinical implications. Ophthal Surg Lasers Imaging Retina 48(2):160–166CrossRefGoogle Scholar
- 17.Ternent L, Vale L, Boachie C, Burr JM, Lois N, Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group (2012) Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial. Br J Ophthalmol 96:438–443CrossRefGoogle Scholar
- 28.Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(1087–1093):e3Google Scholar